[go: up one dir, main page]

DE60010464D1 - Geschmackskaschierte flüssige arzneizubereitungen - Google Patents

Geschmackskaschierte flüssige arzneizubereitungen

Info

Publication number
DE60010464D1
DE60010464D1 DE60010464T DE60010464T DE60010464D1 DE 60010464 D1 DE60010464 D1 DE 60010464D1 DE 60010464 T DE60010464 T DE 60010464T DE 60010464 T DE60010464 T DE 60010464T DE 60010464 D1 DE60010464 D1 DE 60010464D1
Authority
DE
Germany
Prior art keywords
liquid medicine
medicine preparations
flavored liquid
flavored
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60010464T
Other languages
English (en)
Other versions
DE60010464T2 (de
Inventor
Danny Yu
Edward Roche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60010464D1 publication Critical patent/DE60010464D1/de
Application granted granted Critical
Publication of DE60010464T2 publication Critical patent/DE60010464T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60010464T 1999-07-09 2000-06-21 Geschmackskaschierte flüssige arzneizubereitungen Expired - Fee Related DE60010464T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14301999P 1999-07-09 1999-07-09
US143019P 1999-07-09
PCT/US2000/016969 WO2001003698A1 (en) 1999-07-09 2000-06-21 Taste masked pharmaceutical liquid formulations

Publications (2)

Publication Number Publication Date
DE60010464D1 true DE60010464D1 (de) 2004-06-09
DE60010464T2 DE60010464T2 (de) 2005-05-12

Family

ID=22502238

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60010464T Expired - Fee Related DE60010464T2 (de) 1999-07-09 2000-06-21 Geschmackskaschierte flüssige arzneizubereitungen

Country Status (25)

Country Link
US (2) US6482823B1 (de)
EP (1) EP1194153B1 (de)
JP (1) JP2003504335A (de)
KR (2) KR20020029668A (de)
CN (1) CN1174740C (de)
AR (1) AR027179A1 (de)
AT (1) ATE265852T1 (de)
AU (1) AU773555B2 (de)
BR (1) BR0012326A (de)
CA (1) CA2377916C (de)
DE (1) DE60010464T2 (de)
DK (1) DK1194153T3 (de)
EE (1) EE05147B1 (de)
ES (1) ES2219360T3 (de)
HR (1) HRP20020119A2 (de)
HU (1) HUP0201765A3 (de)
IL (2) IL147510A0 (de)
MX (1) MXPA02000331A (de)
NO (1) NO20020086L (de)
NZ (1) NZ516486A (de)
PL (1) PL197812B1 (de)
PT (1) PT1194153E (de)
SK (1) SK322002A3 (de)
TR (1) TR200200710T2 (de)
WO (1) WO2001003698A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001080826A2 (en) * 2000-04-20 2001-11-01 Bristol-Myers Squibb Company Taste masking coating composition
JP2004535370A (ja) * 2001-03-05 2004-11-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 味をマスクした液体製薬学的組成物
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
AU2003257093A1 (en) * 2002-08-02 2004-02-23 Eggs In The Pipeline, Llc. System for adding consumable enhancing additives to drinking water
US20080020096A1 (en) * 2003-08-01 2008-01-24 Blum Bradley J System for Adding Consumable Enhancing Additives to Drinking Water
WO2005025622A1 (ja) * 2003-09-12 2005-03-24 Ryukakusan Co. Ltd. 苦みマスキング粒状ゼリー飲料
US7378015B2 (en) * 2003-12-18 2008-05-27 The Clorox Company Filtered water enhancements
US7713482B2 (en) 2003-12-18 2010-05-11 The Clorox Company Control scheme for enhanced filtered water systems
CA2561855A1 (en) 2004-04-12 2005-10-20 Pfizer Products Inc. Taste-masked drugs in rupturing multiparticulates
JP2006232789A (ja) * 2005-02-28 2006-09-07 Sawai Pharmaceutical Co Ltd 経口製剤用組成物及びその製造方法
US20060216355A1 (en) * 2005-03-28 2006-09-28 Donald Spector Encapsulated pharmaceuticals in a medium having non-encapsulated flavoring agents
US7874489B2 (en) * 2005-06-20 2011-01-25 Authentiform Technologies, Llc Product authentication
WO2007002009A2 (en) * 2005-06-20 2007-01-04 Johnson & Johnson Product authentication
US8247018B2 (en) * 2005-06-20 2012-08-21 Authentiform Technologies, Llc Methods for quality control
US20070197469A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V Fluoroquinolone carboxylic acid salt compositions
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
EP2091519B1 (de) 2006-11-30 2015-06-24 Bend Research, Inc Multiteilchen eines spray-überzogenen arzneimittels und polymer auf einem schmelzbaren kern
US20110038933A1 (en) * 2008-05-06 2011-02-17 Dexcell Ltd. Stable benzimidazole formulation
CN101618217B (zh) * 2009-07-27 2011-12-28 洛阳君山制药有限公司 一种安胃片的包衣方法
KR101636958B1 (ko) * 2009-09-11 2016-07-06 주식회사 대웅제약 우루소데옥시콜린산-합성하이드로탈사이트-유드라짓 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법
EP2509631A4 (de) * 2009-12-10 2014-04-02 Monosol Rx Llc Ph-empfindliche verbindungen für eine geschmacksverbergung in oral einnehmbaren dünnschichtstreifen
US9629920B2 (en) 2009-12-18 2017-04-25 Exodos Life Sciences Limited Partnership Methods and compositions for stable liquid drug formulations
WO2014070958A1 (en) 2012-10-30 2014-05-08 Certirx Corporation Product, image, or document authentication, verification, and item identification
EP2968354B1 (de) 2013-03-15 2019-11-13 Aprecia Pharmaceuticals LLC Schnell zerfallende darreichungsform von oxcarbazepin
ES2761407T3 (es) 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Forma de dosificación rápidamente dispersable de topiramato
US11173135B2 (en) 2016-03-17 2021-11-16 Thiogenesis Therapeutics, Inc. Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
KR102088315B1 (ko) 2017-10-23 2020-03-13 주식회사 웅진릴리에뜨 장용성 캡슐의 이취 마스킹 방법 및 이를 이용한 이취의 마스킹 처리가 이루어진 장용성 캡슐
WO2019142063A1 (en) * 2018-01-22 2019-07-25 Johnson & Johnson Consumer Inc. Perforated capsules
WO2020104837A1 (en) 2018-11-21 2020-05-28 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN117503701A (zh) * 2023-12-08 2024-02-06 斯坦德医药研发(江苏)有限公司 左氧氟沙星口服混悬液制剂及制剂制造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62226926A (ja) 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
US5065094A (en) 1990-08-07 1991-11-12 Seagate Technology, Inc. Two terminal magnetoresistive sensor having DC blocking capacitor
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5599556A (en) 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE4200821A1 (de) 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
FR2694751B1 (fr) 1992-08-14 1994-11-25 Bouchara Sa Nouveaux dérivés sulfonamides, leurs procédés de préparation et les compositions en renfermant.
US5614222A (en) * 1994-10-25 1997-03-25 Kaplan; Milton R. Stable aqueous drug suspensions and methods for preparation thereof

Also Published As

Publication number Publication date
PL352761A1 (en) 2003-09-08
MXPA02000331A (es) 2002-06-21
EE05147B1 (et) 2009-04-15
SK322002A3 (en) 2003-02-04
WO2001003698A1 (en) 2001-01-18
ES2219360T3 (es) 2004-12-01
IL147510A (en) 2007-06-03
AU773555B2 (en) 2004-05-27
US20030064107A1 (en) 2003-04-03
CN1360504A (zh) 2002-07-24
CA2377916C (en) 2008-03-11
NO20020086D0 (no) 2002-01-08
HRP20020119A2 (en) 2003-12-31
HUP0201765A3 (en) 2004-05-28
KR20020029668A (ko) 2002-04-19
KR100675809B1 (ko) 2007-02-01
IL147510A0 (en) 2002-08-14
AR027179A1 (es) 2003-03-19
NZ516486A (en) 2003-10-31
EP1194153A1 (de) 2002-04-10
CA2377916A1 (en) 2001-01-18
EE200200012A (et) 2003-02-17
KR20020031382A (ko) 2002-05-01
HUP0201765A2 (hu) 2002-11-28
NO20020086L (no) 2002-03-05
JP2003504335A (ja) 2003-02-04
TR200200710T2 (tr) 2002-08-21
PL197812B1 (pl) 2008-04-30
US6586012B2 (en) 2003-07-01
EP1194153B1 (de) 2004-05-06
AU5880200A (en) 2001-01-30
ATE265852T1 (de) 2004-05-15
DK1194153T3 (da) 2004-08-02
DE60010464T2 (de) 2005-05-12
US6482823B1 (en) 2002-11-19
PT1194153E (pt) 2004-09-30
BR0012326A (pt) 2002-03-12
CN1174740C (zh) 2004-11-10

Similar Documents

Publication Publication Date Title
DE60010464D1 (de) Geschmackskaschierte flüssige arzneizubereitungen
ATE352339T1 (de) Medikamentspender
EE200200038A (et) Konservitud farmatseutilised preparaadid
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE60011853D1 (de) Injektionsspritze
NO20071303L (no) Farmasoytiske preparater
ATE311915T1 (de) Medikamentenspender
IS6040A (is) Valdekoxib efnablöndur
NO20014490D0 (no) Medisinske blandinger
DE60029219D1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
NO20020531D0 (no) Beta-carbolin medikament produkter
NO20022606D0 (no) Farmasöytiske kombinasjoner
DK1275397T3 (da) Lægemiddel til lokal anvendelse
NO20026013L (no) Medisinske preparater inneholdende propenonderivater
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
ATE298576T1 (de) Arzneizubereitungen
NO20016430L (no) Farmasöytisk kompleks
ATE237309T1 (de) Arzneizubereitungen
EP1142589A4 (de) Medizinische zusammensetzungen
IT1316440B1 (it) Cannula erogatrice di unguenti medicinali.
DE69904021D1 (de) Flüsige pharmazeusche zubereitung enthaltend zotepin
DE50009295D1 (de) Vernetzerfreie zubereitungen
EA200100275A1 (ru) Антиаритмическое лекарственное средство
UA3830S (uk) Етикетка медичного препарату
UA3831S (uk) Етикетка медичного препарату

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee